Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates

Emerging SARS-CoV-2 variants and the gradually decreasing neutralizing antibodies over time post vaccination have led to an increase in incidents of breakthrough infection across the world. To investigate the potential protective effect of the recombinant protein subunit COVID-19 vaccine targeting r...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qian, Mao, Qunying, Peng, Xiaozhong, He, Zhanlong, Lu, Shuaiyao, Zhang, Jialu, Gao, Fan, Bian, Lianlian, An, Chaoqiang, Yu, Wenhai, Yang, Fengmei, Zhou, Yanan, Yang, Yun, Li, Yanyan, Yuan, Yadi, Yan, Xujia, Yang, Jinghuan, Wu, Xing, Huang, Weijin, Li, Changgui, Wang, Junzhi, Liang, Zhenglun, Xu, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892123/
https://www.ncbi.nlm.nih.gov/pubmed/35241645
http://dx.doi.org/10.1038/s41392-022-00926-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892123/
https://www.ncbi.nlm.nih.gov/pubmed/35241645
http://dx.doi.org/10.1038/s41392-022-00926-y

Ejemplares similares